GenoMed4ALL

Accumulating evidence points towards personalised medicine to treat and manage common, rare and ultra-rare haematological diseases. To address this need and further support research, the EU-funded GenoMed4ALL project will develop a data-sharing platform employing novel advanced artificial intelligence (AI) models. The project's partners will share and direct their infrastructures, powerful computing facilities, hospital registries and data processing tools towards this effort.   

Thus, the GENOMED4ALL aims to demonstrate the potential and benefits of trustable and explainable AI technologies, applying a novel approach to AI models and algorithms using advanced deep learning in combination with advanced statistical and machine learning processes to exploit the powerful set of omics data, which will be at researchers’ disposal. This will allow the identification of new knowledge, to support clinical research and decision making by linking Europe's relevant genomic repositories in haematological diseases, while ensuring full compliance with data protection legislation and ethical principles, and increasing the AI trust for personalized medicine. Collectively, these tools will lead to improved therapies and better clinical outcomes.